Cover Image
Market Research Report

Contract Pharmaceutical Manufacturing Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published by Coherent Market Insights Product code 769550
Published Content info 224 Pages
Delivery time: 2-3 business days
Price
Back to Top
Contract Pharmaceutical Manufacturing Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Published: December 27, 2018 Content info: 224 Pages
Description

Report Description

  • Pharmaceutical companies are now pushing hard to reduce overall manufacturing and research costs by outsourcing various processes related to research, development and manufacturing. Furthermore, patent expiration and generic drug competition, continue to fuel demand for pharmaceutical contract manufacturing organizations in the market.
  • Rising number of Food and Drug Administration (FDA) approvals and clinical trials are supporting growth of biopharmaceutical industry, which in turn is fueling growth of the contract pharmaceutical manufacturing market. For instance, according to ClinicalTrials.gov, from September 2008 to October 2018, there were around 288,064 clinical trial studies registered. In addition, there is a significant increase over the past few years with registered clinical studies of 205,428, 233,234, and 262,429 in 2015, 2016, and 2017, respectively.
  • Furthermore, stringent regulatory policies for clinical research studies and manufacturing make entire drug manufacturing process more complex, as it requires more resources to develop new drugs and biologics. These processes require expertise in broad scientific disciplines of preclinical, clinical, ancillary clinical in chemistry, packaging, manufacturing, project management, and regulatory affairs, which are provided by the CROs and CMOs. This is considered as a major reason for pharmaceutical companies to outsource clinical trials and manufacturing processes.

Market Dynamics

  • Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to the complexity involved in manufacturing process of biomolecules, as it consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Furthermore, by outsourcing manufacturing capabilities from contract manufacturing organization, allows recruiter firms to focus more on the research and development (R&D), product development, and marketing aspects.
  • Pharmaceutical market is increasingly concentered with generic products and is highly competitive with various companies located in Asia Pacific, which are entering into the developed markets such as the U.S., Germany, France, and the U.K. Rising number of patents expiring in the near future serves to be a major opportunity for generic drugs manufacturers to prosper in the market.
  • Furthermore, mergers and acquisitions between generic drug manufacturers, with major players focusing on enhancing their product portfolio through inorganic strategies, will support the addition of generic drug portfolio into company's offering and thus, generating demand for CMOs to fulfil it.
  • For instance, in August 2016, Teva Pharmaceuticals Industries strengthened its position in the generic drugs market through acquisition of the generic segment of Allergan, plc for US$ 40.5 billion. This resulted in significant growth in revenue contribution of its generic drug segment, pegged at US$ 9.5 billion in 2016.

Key features of the study:

  • This report provides in-depth analysis of contract pharmaceutical manufacturing market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global contract pharmaceutical manufacturing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies.
  • Key companies covered as a part of this study includes Accenture plc, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation, Quintiles Transnational Corporation, Abbvie, Inc., Baxter International Inc., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd. and Piramal Enterprises Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type upgradation, market expansion, and marketing tactics.
  • The global contract pharmaceutical manufacturing market report caters to various stakeholders in this industry including investors, researchers, contract pharmaceutical manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the contract pharmaceutical manufacturing market.

Detailed Segmentation:

  • Global contract pharmaceutical manufacturing market, By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
  • Global Contract Pharmaceutical Manufacturing Market, By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Global Contract Pharmaceutical Manufacturing Market, By Geography:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
    • By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
    • By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
    • By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
    • By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
    • By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
    • By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Africa
    • By Country:
  • North Africa
  • Central Africa
  • South Africa
    • By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb - IV
    • Medical coding and writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site management
    • Protocol development
    • By Molecule Type:
  • Small Molecules
  • Large Molecules
  • Company Profiles
  • Accenture plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
  • Cognizant Technology Solutions
  • ATOS SE
  • Catalent, Inc.
  • Covance, Inc.
  • Boehringer Ingelheim GmbH
  • Genpact Limited
  • Lonza Group
  • PAREXEL International Corporation
  • Quintiles Transnational Corporation
  • Abbvie, Inc.
  • Baxter International Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Pfizer, Inc.
  • The Almac Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Molecule Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Strategic Acquisitions
  • Strategic Collaborations
  • Top 10 Contract Research Organizations (2016)
  • Clinical Trial Trends

4. Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Contract Manufacturing Organization (CMO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • API Manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Final dosage form manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Packaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Contract Research Organization (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Preclinical Studies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Early Phase I - IIa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Phase IIa - III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Phase IIIb - IV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Medical Coding and Writing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Clinical Data Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Bio-statistics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Site Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Protocol Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Small Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Large Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Contract Pharmaceutical Manufacturing Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
  • North America
    • Market Size and Forecast, By Service Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Molecule Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Service Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Molecule Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Service Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Molecule Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Service Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Molecule Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Service Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Molecule Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Service Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Molecule Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Accenture plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Cognizant Technology Solutions
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • ATOS SE
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Catalent, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Covance, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Boehringer Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Genpact Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Lonza Group
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • PAREXEL International Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Quintiles Transnational Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Abbvie, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Baxter International Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Aurobindo Pharma
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • The Almac Group
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Piramal Enterprises Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top